The SLIT2/ROBO1 pathway has been shown to be involved in the progression of intrahepatic cholangiocarcinoma (ICC) [73], breast [74] and bowel cancer [75]. This evidence concerns the gene ROBO1 and intrahepatic cholangiocarcinoma.